VivaVision Biotech

About:

VivaVision Biotech is a clinical-stage R&D biopharmaceutical company that is developing novel medicines to treat topical diseases.

Website: http://www.vivavisionbio.com/en/index.php?a=lists&catid=6

Top Investors: HongShan, Viva BioInnovator, JMCR Partners, Cenova, ShenZhen GTJA Investment Group

Description:

VivaVision Biotech is a clinical-stage R&D biopharmaceutical company that is developing novel medicines to treat topical diseases. VivaVision Biotech is dedicated to bringing new therapeutics to millions of patients suffering from chronic ocular or dermal inflammatory diseases.

Total Funding Amount:

431M CNY

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Shanghai, Shanghai, China

Founded Date:

2016-01-01

Founders:

Wang Shen

Number of Employees:

1-10

Last Funding Date:

2023-05-05

IPO Status:

Private

Industries:

© 2025 bioDAO.ai